Table 3

Initial laboratory data of liver transplant recipient with SARS-CoV-2 infection

Patients tested, n (%)ResultsPatients with value, n
Deviation from reference (%)
Blood counts, median (IQR)
 Leucocytes (×1000/μL)51 (90)4.50 (3.33–6.00)17 (33)*
 Platelets (×1000/μL)49 (86)160 (91–268)17 (35)*
 Lymphocytes (×1000/μL)49 (86)0.79 (0.40–1.10)37 (76)*
Biochemical and liver-related test, median (IQR)
 AST (U/L)49 (86)38 (25–53)13 (26)†
 ALT (U/L)49 (86)30 (20–42)10 (20)†
 GGT (U/L)45 (79)66 (39–161)29 (64)†
 ALP (U/L)37 (65)97 (74–171)9 (24)†
 Total bilirubin (mg/dL)43 (75)0.70 (0.48–1.09)10 (23)†
 INR (ratio)42 (74)1.10 (1.03–1.28)14 (33)†
 Albumin (g/L)19 (33)32 (29.5–36.5)8 (42)*
 Creatinine (mg/dL)50 (88)1.16 (0.93–1.55)20 (40)†
 Glucose (mg/dL)36 (63.2)127.5 (92.5–163.0)24 (67)†
Inflammatory-related markers, median (IQR)
 D-Dimer (ng/mL)17 (29.8)871 (380–1739)10 (59)†
 LDH (U/L)31 (54.4)273 (192–384)20 (65)†
 IL-6 (pg/L)9 (15.8)93 (59–288)
 Ferritin (ng/mL)13 (22.8)567 (171–1194)9 (69)†
  • *Below reference.

  • †Above reference.

  • ALP, alanine alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyltransferase; IL-6, interleukin-6; INR, international normalised ratio; LDH, lactate dehydrogenase.